Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oncolytics Biotech (ONCY)
NASDAQ:ONCY
RESEARCH TOOLSreports
Oncolytics Biotech (ONCY) Stock Forecast & Price Target
1,088 Followers
See the Price Targets and Ratings of:
ONCY Analyst Ratings
Strong Buy
3 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ONCY Stock 12 Month Forecast
Average Price Target
$4.80
▲(366.02% Upside)
| Highest Price Target$5.00 | Average Price Target$4.80 | Lowest Price Target$4.40 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
H.C. Wainwright
Reiterated
05/14/24
Raymond James
$2.2
Buy
113.54%
Upside
Initiated
04/04/24
Oncolytics initiated with an Outperform at Raymond JamesOncolytics initiated with an Outperform at Raymond James
JonesTrading
$6.6
Buy
540.63%
Upside
Reiterated
03/08/24
Buy Rating Affirmed on Oncolytics Biotech Amid Progress and Strategic Clinical Trials
Canaccord Genuity
$5
Buy
385.44%
Upside
Reiterated
11/03/23
Positive Outlook for Oncolytics Biotech: Upcoming Clinical Trials, Business Developments, and Solid Financial Position Drive Buy Rating
Best Analysts Covering Oncolytics Biotech
Which Analyst Should I Follow If I Want to Buy ONCY and Sell After:
1 Month
3 Months
1 Year
Success Rate
6/21 ratings generated profit
Average Return
-14.17%
assigned a buy rating 2 months ago
Copying Douglas Miehm's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -14.17% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ONCY Analyst Recommendation Trends
Rating
Feb 24
Mar 24
Apr 24
May 24
Jun 24
Strong Buy
4
7
6
7
4
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
7
6
7
4
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
ONCY Financial Forecast
ONCY Stock Forecast FAQ
What is ONCY’s average 12-month price target, according to analysts?
Based on analyst ratings, Oncolytics Biotech’s 12-month average price target is $4.80.
What is ONCY’s upside potential, based on the analysts’ average price target?
Oncolytics Biotech has 366.02% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ONCY a Buy, Sell or Hold?
Oncolytics Biotech has a consensus rating of Strong Buy which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Oncolytics Biotech’s price target?
The average price target for Oncolytics Biotech is $4.80. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $5.00 ,the lowest forecast is $4.40. The average price target represents 366.02% Increase from the current price of $1.03.
The highest analyst price target is $5.00 ,the lowest forecast is $4.40. The average price target represents 366.02% Increase from the current price of $1.03.
What do analysts say about Oncolytics Biotech?
Oncolytics Biotech’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of ONCY?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.